李晓艳

摘要：目的 探讨肿节风注射剂与灯盏花素注射剂在类风湿关节炎治疗中的应用效果。方法 随机选取本院76例类风湿关节炎患者，时间选自2019年3月-2020年7月，随机分组，甲组（38例）实施肿节风注射剂治疗，乙组（38例）采取灯盏花素注射剂治疗，对两组治疗效果进行比较。结果 治疗总有效率方面，甲组是94.74%，乙组是92.11%，两组对比，差异较小（P>0.05）;关节肿胀与关节疼痛评分方面，两组治疗前及治疗后均未见明显差异（P>0.05）。结论 肿节风注射剂与灯盏花素注射剂均在类风湿关节炎治疗中具有显著应用效果，其有助于患者关节肿胀及疼痛等临床症状及早缓解，促进整体治疗效果和生活质量的提高，值得临床采纳、推广。

关键词：类风湿关节炎;灯盏花素注射剂;肿节风注射剂

[Abstract]Objective To explore the application effect of Zhongjiefeng injection and Breviscapine Injection in the treatment of rheumatoid arthritis. Methods 76 patients with rheumatoid arthritis in our hospital were randomly selected from March 2019 to July 2020. They were randomly divided into group A（38 cases）and group B（38 cases）. Results the total effective rate was 94.74% in group A and 92.11% in group B. There was little difference between the two groups（P > 0.05）;There was no significant difference in the scores of joint swelling and pain between the two groups before and after treatment（P > 0.05）. Conclusion both Zhongjiefeng injection and Breviscapine injection have significant application effect in the treatment of rheumatoid arthritis，which can help patients with joint swelling and pain relieve as soon as possible，promote the overall treatment effect and improve the quality of life，and is worthy of clinical adoption and promotion.

[Key words]rheumatoid arthritis;Breviscapine injection;Zhongjiefeng injection

類风湿关节炎是临床常见、多发疾病之一，具有多关节炎等症状，到目前为止，疾病诱因尚不明确【1】。中医将类风湿关节炎归于痹症的范围内，其认为该病是由于湿热风寒、正气不足等造成骨节、肌肉等血液运行受阻，累及肾、肝等，最终导致该病的发生【2】。临床上，主要采用化瘀活血药物治疗，基于此，本次研究主要针对类风湿关节炎患者采取肿节风注射剂与灯盏花素注射剂治疗的效果进行分析，具体如下。

1 资料与方法

1.1 资料

本次研究76例类风湿关节炎患者均为本院2019年3月-2020年7月接收，随机分组，各38例;甲组：22例男，16例女;最小、最大年龄分别是20岁与74岁，均值（45.32±3.12）岁;乙组：24例男，14例女;最小、最大年龄分别是20岁与72岁，均值（45.28±3.15）岁;一般资料方面，两组比较，差异较小（P>0.05）。……